|

Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS)

RECRUITINGSponsored by China-Japan Friendship Hospital
Actively Recruiting
SponsorChina-Japan Friendship Hospital
Started2024-01-01
Est. completion2026-12-31
Eligibility
Age16 Years – 70 Years
View on ClinicalTrials.gov →

NCT06169033

Summary

Using radiomics of intra-abdominal and subcutaneous adipose tissue and clinical features to predict the weight loss efficacy and remission of type 2 diabetes mellitus after bariatric surgery.

Eligibility

Age: 16 Years – 70 Years
Inclusion Criteria:

* BMI\>27.5kg/m2; Type 2 diabetes mellitus; Patients who will undergo bariatric surgery

Exclusion Criteria:

* Patients without abdominal CT scan; Patients did not undergo sleeve gastrectomy or Roux-en-Y gastric bypass.

Conditions4

Bariatric SurgeryDiabetesObesityType 2 Diabetes Mellitus

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.